Restricted accessResearch articleFirst published online 2018-10
Effects of brief mindfulness-based cognitive behavioural therapy on health-related quality of life and sense of coherence in atrial fibrillation patients
The aim of this study was to evaluate the effects of a brief dyadic cognitive behavioural therapy (CBT) programme on the health-related quality of life (HRQoL), as well as the sense of coherence in atrial fibrillation patients, up to 12 months post atrial fibrillation.
Methods:
A longitudinal randomised controlled trial with a pre and 12-month post-test recruitment of 163 persons and their spouses, at a county hospital in southern Sweden. In all, 104 persons were randomly assigned to either a CBT (n=56) or a treatment as usual (TAU) group (n=55). The primary outcome was changes in the HRQoL (Euroqol questionnaire; EQ-5D), and the secondary outcomes were changes in psychological distress (hospital anxiety and depression scale; HADS) and sense of coherence (sense of coherence scale; SOC-13).
Results:
At the 12-month follow-up, the CBT group experienced a higher HRQoL than the TAU group (mean changes in the CBT group 0.062 vs. mean changes in the TAU group −0.015; P=0.02). The sense of coherence improved in the CBT group after the 12-month follow-up, compared to the TAU group (mean changes in the CBT group 0.062 vs. mean changes in the TAU group −0.16; P=0.04). The association between the intervention effect and the HRQoL was totally mediated by the sense of coherence (z=2.07, P=0.04).
Conclusions:
A dyadic mindfulness-based CBT programme improved HRQoL and reduced psychological distress up to 12 months post atrial fibrillation. The sense of coherence strongly mediated the HRQoL; consequently, the sense of coherence is an important determinant to consider when designing programmes for atrial fibrillation patients.
CutugnoCL.CE: Atrial fibrillation: updated management guidelines and nursing implications. Am J Nurs2015; 115: 26–38; quiz 39, 49.
2.
EkbladHet al. Patients’ well-being: experience and actions in their preventing and handling of atrial fibrillation. Eur J Cardiovasc Nurs2013; 12: 132–139.
3.
McCabePJ.Psychological distress in patients diagnosed with atrial fibrillation: the state of the science. J Cardiovasc Nurs2010; 25: 40–51.
4.
LindstromBErikssonM.Contextualizing salutogenesis and Antonovsky in public health development. Health Promot Int2006; 21: 238–244.
5.
KotechaDet al. Patient-reported outcomes for quality of life assessment in atrial fibrillation: a systematic review of measurement properties. PLoS One2016; 11: e0165790.
6.
BergmanEet al. The impact of comprehensibility and sense of coherence in the recovery of patients with myocardial infarction: a long-term follow-up study. Eur J Cardiovasc Nurs2012; 11: 276–283.
7.
ChughSSet al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation2014.;129: 837–847.
8.
LowresNet al. Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost201; 110: 213–222.
9.
NordblomAKBrostromAFridlundB.Impact on a person’s daily life during episodes of supraventricular tachycardia: a qualitative content analysis from a holistic perspective. J Holist Nurs2017; 35: 33–43.
10.
AntonovskyA.Unraveling the mystery of health. London: Jossey-Bass, 1987.
11.
KristofferzonMLLofmarkRCarlssonM.Perceived coping, social support, and quality of life 1 month after myocardial infarction: a comparison between Swedish women and men. Heart Lung2005; 34: 39–50.
12.
TurnerAHambridgeJBakerA.Randomized controlled trial of group cognitive behavior therapy versus brief intervention for depression in cardiac patients. Aust NZ Psychiatry2013; 47: 235–243.
13.
BarthJPaulJHärterM.Inpatient psychotherapeutic treatment for cardiac patients with depression in Germany – short term results. Psychosoc Med2005; 2: 1–7.
14.
GullikssonMBurellGVessbyBet al. Randomized controlled trial of cognitive behavioral therapy vs. standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM). Arch Intern Med2011; 171: 134–140.
15.
SegalZVWilliamsJMGTeasdaleJD.Mindfulness-Based Cognitive Therapy for Depression, 2nd ed.New York: The Guilford Press, 2016.
16.
SegalZVWilliamsJTeasdaleJD.Mindfulness-Based Cognitive Therapy for Depression: a New Approach to Preventing Relapse. New York: The Guilford Press, 2002.
BohlmeijerEet al. The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: a meta-analysis. J Psychosom Res2010; 68: 539–544.
19.
LawrenceMet al. A systematic review of the benefits of mindfulness-based interventions following transient ischemic attack and stroke. Int J Stroke2013; 8: 465–474.
20.
DittoBEclacheMGoldmanN.Short-term autonomic and cardiovascular effects of mindfulness body scan meditation. Ann Behav Med2006; 32: 227–234.
21.
LongabaughR.Involvement of support networks in treatment. In: GalanterM (ed.) Recent developments in alcoholism. USA: Springer, 2002, pp.133–147.
22.
EkbladHet al. The well-being of relatives of patients with atrial fibrillation: a critical incident technique analysis. Open Nurs J2014; 8: 48–55.
23.
BohnenMet al. Quality of life with atrial fibrillation: do the spouses suffer as much as the patients?Pacing Clin Electrophysiol2011; 34: 804–809.
24.
DaltegTet al. Managing uncertainty in couples living with atrial fibrillation. J Cardiovasc Nurs2014; 29: E1–E10.
25.
DaltegTet al. Associations of emotional distress and perceived health in persons with atrial fibrillation and their partners using the actor–partner interdependence model. J Fam Nurs2016; 22: 368–391.
26.
SmithDEet al. Trial of an educational intervention on patients’ knowledge of atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT). BMC Cardiovasc Disord2010; 10: 21.
27.
LowresNet al, Choice of health options in prevention of cardiovascular events for people with atrial fibrillation (CHOICE-AF): a pilot study. Eur J Cardiovasc Nurs2016; 15: 39–46.
28.
LowresNet al. Lifestyle risk reduction interventions in atrial fibrillation: a systematic review. Eur J Prev Cardiol2012; 19: 1091–1100.
29.
DickensCCherringtonAMcGowanL.Depression and health-related quality of life in people with coronary heart disease: a systematic review. Eur J Cardiovasc Nurs2012; 11: 265–275.
30.
FaulFet al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods2007; 39: 175–191.
31.
WallentinLet al. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation2013; 127: 2166–2176.
32.
ChapmanSAet al. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS2 and CHA2DS2-VASc score levels and warfarin prescription for adult patients with atrial fibrillation. BMC Health Serv Res2017; 17: 127.
33.
CammAJet al. 2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J2012; 33: 2719–2747.
34.
HeartMath. 100 Countries 25,000 Health professionals Millions of lives transformed, www.heartmath.com/health-professionals (2017, accessed 10 November 2017).
35.
ChildreDMartinH.The HeartMath Solution. New York: Harper Collins Publishers, 1999.
36.
KleenMReitsmaB.Appliance of heart rate variability biofeedback in acceptance and commitment therapy: a pilot study. J Neurother2011; 15: 170–181.
37.
ChildreDRozmanD.The HeartMath Solution to Relieving Worry, Fatigue, and Tension. Oakland, CA: New Harbinger Publishers, 2005.
38.
PattersonGTChungIWSwanPW.Stress management interventions for police officers and recruits: a meta-analysis. J Exp Criminol2014; 10: 487–513.
39.
BurstromKet al. Swedish experience-based value sets for EQ-5D health states. Qual Life Res2014; 23: 431–442.
40.
LarssonGKallenbergK.Sense of coherence, socioeconomic conditions and health Interrelationships in a nation-wide Swedish sample. Eur J Public Health1996; 6: 175–180.
41.
LisspersJNygrenASodermanE.Hospital anxiety and depression scale (HAD): some psychometric data for a Swedish sample. Acta Psychiatr Scand1997; 96: 281–286.
42.
De SmedtDet al. Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey. Int J Cardiol2013; 168: 898–903.
43.
GottliebSSet al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol2004; 43: 1542–1549.
44.
YaghoubiAet al. Quality of life in cardiovascular patients in Iran and factors affecting it: a systematic review. J Cardiovasc Thorac Res2012; 4: 95–101.
45.
BaronRMKennyDA.The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol1986; 51: 1173–1182.
46.
BenjaminiYHochbergY.Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B (Statistical Methodology)1995; 57: 289–300.
47.
JulkunenJAhlstromR.Hostility, anger, and sense of coherence as predictors of health-related quality of life. Results of an ASCOT substudy. J Psychosom Res2006; 61: 33–39.
48.
ASCOT-LLA. Extended ASCOT – lipid lowering (ASCOT-LLA) study shows positive results of atorvastatin. Cardiovasc J Afr2008; 19: 49–51.
49.
AgrenSEvangelistaLStrombergA.Do partners of patients with chronic heart failure experience caregiver burden?Eur J Cardiovasc Nurs2010; 9: 254–262.
50.
SilarovaBet al. Sense of coherence as a mediator between hostility and health-related quality of life among coronary heart disease patients. Heart Lung2016; 45: 126–131.
51.
RohaniCet al. Sense of coherence as a mediator of health-related quality of life dimensions in patients with breast cancer: a longitudinal study with prospective design. Health Qual Life Outcomes2015; 13: 195.
